Key Financial Data Of Reporting Company

ZERIA PHARMCEUTICAL CO., LTD. - Filing #7247022

Concept As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
87,311,137,000 JPY
34,710,973,000 JPY
34,017,192,000 JPY
75,725,075,000 JPY
32,960,174,000 JPY
68,383,227,000 JPY
31,956,515,000 JPY
59,532,829,000 JPY
31,570,550,000 JPY
52,757,184,000 JPY
Ordinary profit (loss)
12,840,865,000 JPY
3,422,223,000 JPY
2,686,502,000 JPY
8,513,028,000 JPY
2,738,392,000 JPY
7,579,449,000 JPY
1,594,058,000 JPY
5,935,646,000 JPY
1,088,929,000 JPY
3,208,652,000 JPY
Profit (loss)
2,859,112,000 JPY
1,636,470,000 JPY
2,157,832,000 JPY
1,392,594,000 JPY
1,273,783,000 JPY
Share capital
6,593,398,000 JPY
6,593,398,000 JPY
6,593,398,000 JPY
6,593,398,000 JPY
6,593,398,000 JPY
Total number of issued shares
53,119,190 xbrli:shares
53,119,190 xbrli:shares
53,119,190 xbrli:shares
53,119,190 xbrli:shares
53,119,190 xbrli:shares
Net assets
89,797,027,000 JPY
41,016,739,000 JPY
79,828,792,000 JPY
40,035,077,000 JPY
38,023,049,000 JPY
65,680,710,000 JPY
55,092,474,000 JPY
38,252,193,000 JPY
56,152,673,000 JPY
41,329,422,000 JPY
Total assets
159,171,596,000 JPY
90,023,301,000 JPY
150,533,593,000 JPY
92,940,742,000 JPY
92,091,084,000 JPY
135,034,536,000 JPY
124,282,333,000 JPY
94,903,838,000 JPY
121,860,440,000 JPY
95,027,702,000 JPY
Net assets per share
2,031.33
930.52
1,806.33
908.24
862.59
1,484.79
1,236.09
861.34
1,225.09
904.39
Dividend paid per share
47.00
44.00
40.00
35.00
34.00
Interim dividend paid per share
23.00
22.00
18.00
17.00
17.00
Basic earnings (loss) per share
225.42
64.86
37.12
175.39
48.85
140.26
30.85
87.76
27.65
68.22
Diluted earnings per share
Equity-to-asset ratio
0.563 xbrli:pure
0.456 xbrli:pure
0.529 xbrli:pure
0.431 xbrli:pure
0.413 xbrli:pure
0.485 xbrli:pure
0.442 xbrli:pure
0.403 xbrli:pure
0.459 xbrli:pure
0.435 xbrli:pure
Rate of return on equity
0.117 xbrli:pure
0.071 xbrli:pure
0.042 xbrli:pure
0.107 xbrli:pure
0.057 xbrli:pure
0.103 xbrli:pure
0.035 xbrli:pure
0.071 xbrli:pure
0.030 xbrli:pure
0.058 xbrli:pure
Price-earnings ratio
10.0 xbrli:pure
34.8 xbrli:pure
57.4 xbrli:pure
12.2 xbrli:pure
46.0 xbrli:pure
16.0 xbrli:pure
61.7 xbrli:pure
21.7 xbrli:pure
76.1 xbrli:pure
30.8 xbrli:pure
Payout ratio
0.725 xbrli:pure
1.185 xbrli:pure
0.819 xbrli:pure
1.135 xbrli:pure
1.230 xbrli:pure
Net cash provided by (used in) operating activities
12,922,046,000 JPY
12,183,609,000 JPY
13,157,415,000 JPY
8,950,932,000 JPY
6,894,290,000 JPY
Net cash provided by (used in) investing activities
-1,050,885,000 JPY
-3,952,373,000 JPY
-2,574,517,000 JPY
-2,892,814,000 JPY
-17,460,812,000 JPY
Net cash provided by (used in) financing activities
-7,756,699,000 JPY
-8,124,090,000 JPY
-7,415,068,000 JPY
-4,841,212,000 JPY
11,185,277,000 JPY
Cash and cash equivalents
23,467,676,000 JPY
18,604,144,000 JPY
16,094,078,000 JPY
11,579,282,000 JPY
9,668,938,000 JPY
Number of employees
xbrli:pure
187 xbrli:pure
1,451 xbrli:pure
1,746 xbrli:pure
631 xbrli:pure
7 xbrli:pure
818 xbrli:pure
288 xbrli:pure
709 xbrli:pure
340 xbrli:pure
742 xbrli:pure
291 xbrli:pure
1,777 xbrli:pure
823 xbrli:pure
840 xbrli:pure
1,729 xbrli:pure
1,737 xbrli:pure
859 xbrli:pure
1,690 xbrli:pure
872 xbrli:pure
Average number of temporary employees
xbrli:pure
xbrli:pure
145 xbrli:pure
145 xbrli:pure
137 xbrli:pure
xbrli:pure
137 xbrli:pure
xbrli:pure
101 xbrli:pure
93 xbrli:pure
44 xbrli:pure
44 xbrli:pure
150 xbrli:pure
141 xbrli:pure
135 xbrli:pure
143 xbrli:pure
135 xbrli:pure
125 xbrli:pure
136 xbrli:pure
125 xbrli:pure
Total shareholder return
1.177 xbrli:pure
1.094 xbrli:pure
1.127 xbrli:pure
0.945 xbrli:pure
1.023 xbrli:pure
Total return on share price index
2.134 xbrli:pure
2.168 xbrli:pure
1.534 xbrli:pure
1.450 xbrli:pure
1.421 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.